Please use this identifier to cite or link to this item: https://doi.org/10.1211/0022357021778934
DC FieldValue
dc.titleIsobolographic analysis of the analgesic interactions between ketamine and tramadol
dc.contributor.authorChen, Y.
dc.contributor.authorChan, S.Y.
dc.contributor.authorHo, P.C.
dc.date.accessioned2014-10-29T01:54:52Z
dc.date.available2014-10-29T01:54:52Z
dc.date.issued2002
dc.identifier.citationChen, Y., Chan, S.Y., Ho, P.C. (2002). Isobolographic analysis of the analgesic interactions between ketamine and tramadol. Journal of Pharmacy and Pharmacology 54 (5) : 623-631. ScholarBank@NUS Repository. https://doi.org/10.1211/0022357021778934
dc.identifier.issn00223573
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/106094
dc.description.abstractOwing to different mechanisms of analgesia, we hypothesized that the combination of ketamine and tramadol could produce synergistic or additive antinociceptive effects. Swiss albino mice were administered intraperitoneally with ketamine, tramadol, a combination of ketamine and tramadol, or saline, and the resulting antinociceptive effects were tested in the mouse tail-flick and formalin tests. The potencies of the two drugs alone or in combination were obtained by fitting data to the Sigmoid Emax equation. Isobolographic analysis was performed to evaluate the interaction. CNS depression was also monitored. Results showed that tramadol exhibited apparent dose-dependent effects in the tail-flick test, and in phase 1 and phase 2 of the formalin test. Ketamine dose-dependently inhibited the phase 2 responses, but failed to modify the phase 1 and tail-flick responses. Combination of tramadol and ketamine produced significant synergistic interactions only in phase 2 of the formalin test (P < 0.05). The synergistic combinations also displayed less CNS depression than when an equianalgesic dose of ketamine was administered alone. We conclude that in the acute thermal or chemical pain model, ketamine is not effective and the net effect of ketamine and tramadol in combination was simply additive after systemic administration. However, the coadministration produced synergistic antinociception in the chemical-induced persistent pain model.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1211/0022357021778934
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.1211/0022357021778934
dc.description.sourcetitleJournal of Pharmacy and Pharmacology
dc.description.volume54
dc.description.issue5
dc.description.page623-631
dc.description.codenJPPMA
dc.identifier.isiut000175323000005
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.